| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.0018 | 0.9 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.004 | 1 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.0044 | 1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.004 | 1 |